Australian Radiation Protection and Nuclear Safety Act 1998
Australian Radiation Protection and Nuclear Safety Regulations 1999
Notice of Intention to Make a Declaration of Exemption
In accordance with regulation 37A of the Australian Radiation Protection and Nuclear Safety Regulations 1999 (the Regulations), I, Carl-Magnus Larsson, Chief Executive Officer of the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) hereby notify my intention to make a declaration under sub-regulation 37(1) of the Regulations in the following form:
I, Carl-Magnus Larsson, Chief Executive Officer of ARPANSA, acting under the Australian Radiation Protection and Nuclear Safety Regulations 1999 (the Regulations), hereby conclude that siting a new controlled facility, namely:
The particle accelerator with beam energy of more than 1 MeV, located at the ARPANSA site, 619 Lower Plenty Road, Yallambie VIC,
which is to be controlled by ARPANSA Medical Radiation Services (MRS), will not pose an unacceptable potential hazard to the health and safety of people or the environment and, therefore, satisfies the requirements of sub-regulation 37(1) of the Regulations.
The particle accelerator, specifically a linear accelerator, will be of a typical design producing electrons of up to 20 MeV. It will be operated as a national facility for calibration of radiotherapy linear accelerators in Australia and overseas. The organisation has been operating linear accelerators for the last 20 years on the campus for similar purposes.
Consequently, I exempt MRS from the need to obtain authorisation to prepare a site for the particle accelerator for the purposes of section 30(1)(a) of the Australian Radiation Protection and Nuclear Safety Act 1998, as it will be housed in existing premises.
This Exemption will expire when the facility licence for construction is issued.
Carl-Magnus Larsson
CEO of ARPANSA
19 December 2017
Overview
The Australian Radiation Protection and Nuclear Safety Act 1998 was enacted by the Parliament of Australia to provide for the protection of people and the environment from the harmful effects of ionising radiation, and to regulate the use of nuclear substances. The Act aimed to address the gap in comprehensive regulation concerning radiation protection and nuclear safety, providing a framework for licensing, control, and enforcement. The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) was established under this Act to administer its provisions. The policy objective is to ensure that the use of radiation and nuclear substances is managed in a manner that protects health and safety and minimises risks to the environment. The accompanying Australian Radiation Protection and Nuclear Safety Regulations 1999 further detail the requirements and procedures under the Act, including provisions for exemptions in specific circumstances. This legislative framework ensures that activities involving radiation and nuclear substances are conducted safely and responsibly, aligning with national and international standards.
Scope and Application
The Australian Radiation Protection and Nuclear Safety Act 1998, along with its subsidiary regulations, applies to entities involved in the generation, use, or storage of radiation sources, as well as activities that may expose individuals to radiation or affect the environment. This legislation encompasses a broad range of industries, including medical, industrial, research, and educational sectors that utilise radiation. It mandates the establishment of standards and regulations designed to protect human health and the environment from the risks associated with ionising radiation. The Act's jurisdictional reach is national, extending across the Commonwealth of Australia, and is enforced by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA). Certain activities and substances may be exempt from some provisions of the Act, as illustrated by the notice of intention to make a declaration of exemption for a specific facility, such as the particle accelerator at ARPANSA's site in Yallambie, Victoria. The exemption from authorisation to prepare a site for this facility is based on the assessment that it will not pose an unacceptable potential hazard to health and safety or the environment. This exemption is temporary and will lapse upon the issuance of the facility licence for construction. The Act and Regulations provide for the potential extension and restriction of their application through subordinate instruments, ensuring flexibility and specificity in regulatory enforcement.
Key Provisions
The Australian Radiation Protection and Nuclear Safety Act 1998 (ARPANSA Act) and its accompanying Regulations, including the Australian Radiation Protection and Nuclear Safety Regulations 1999, are designed to regulate the use of radiation and nuclear material in Australia. Regulation 37A of these Regulations allows for the exemption of certain activities from the authorisation requirements stipulated in the Act, provided these activities are deemed to pose no unacceptable risk to health and safety or the environment. Specifically, section 30(1)(a) of the ARPANSA Act mandates that authorisation is required to prepare a site for a controlled facility. However, under the authority of sub-regulation 37(1), Carl-Magnus Larsson, CEO of ARPANSA, has determined that ARPANSA Medical Radiation Services (MRS) does not need to obtain such authorisation for the siting of a new particle accelerator at the ARPANSA site in Yallambie, Victoria. This decision is based on the assessment that the facility, which will be used for the calibration of radiotherapy linear accelerators, does not present an unacceptable hazard to health or the environment.
The obligations imposed by this legislation on the parties involved are primarily centred on ensuring the safe operation and management of radiation and nuclear facilities. MRS, as the operator of the particle accelerator, must adhere to the safety standards and guidelines set out in the ARPANSA Act and the Regulations. This includes ensuring that all activities related to the facility are conducted in a manner that minimises potential risks to health and the environment. The CEO of ARPANSA, in making this declaration, has the responsibility to conduct a thorough assessment of the potential hazards associated with the facility and to ensure that any exemptions granted are justified.
Breaches of the requirements set out in the ARPANSA Act and Regulations can result in both civil and criminal consequences. Under the Act, offences can include the unauthorised use of radiation apparatus, failure to comply with safety standards, and non-compliance with authorisation requirements. The maximum penalties for these offences can vary, but they may include substantial fines and, in some cases, imprisonment. For example, section 40 of the ARPANSA Act outlines penalties for contravening the Act, with maximum penalties reaching up to $1.1 million for corporations and $220,000 for individuals, along with potential imprisonment terms. Additionally, section 37 of the Act allows for the imposition of administrative penalties for breaches of the Regulations, which can include fines of up to $66,000 for corporations and $13,200 for individuals. These provisions underscore the importance of strict adherence to the legislative requirements to avoid legal repercussions.